Savara Pharmaceuticals (stock symbol: SVRA) Logo in transparent PNG format

Savara Pharmaceuticals Logo large

Savara Pharmaceuticals Logo icon format

About Savara Pharmaceuticals

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

  • Website domain:
  • Employees: 22
  • Marketcap: $0.27 Billion USD

Page last updated on:

December 7th, 2020